MIMS Education

Antiviral therapy for COVID-19

Antiviral therapy for COVID-19

General Practice
A badge with ribbon in color black CAT3B: 1 Point | An analog clock in color black 1 Hour | A black calendar with white triangle in center that has a black exclamation point in the middle 21 Apr 2024 


About this course

The treatment options for COVID-19 now include antiviral drugs which prevent the viral replication of SARS-CoV-2 and its clinical manifestations. This e-learning module summarises the essential information on COVID-19 antiviral therapy to enable the timely and appropriate use of antivirals to help reduce the risk of hospitalisation and death associated with COVID-19.

Course objectives/Learning outcomes:

Upon completion of this module, the participant should be able to:
  • Review the pathophysiology of COVID-19
  • Describe the current pharmacological treatments for COVID-19
  • Understand the mechanism of action and efficacy of the different antiviral therapies for COVID-19 in preventing and treating moderate to severe disease
  • Learn guideline recommendations for COVID-19 antiviral therapy

Course overview/Topics covered:

  • COVID-19: Overview and current treatments
  • Prevention of severe COVID-19 disease
  • Treatment of moderate and severe COVID-19 disease
  • Key clinical practice pearls and future perspectives in antiviral therapy

Sponsored by